Qiankun Ni
- Molecular Biology
- Biomedical Engineering top 10%
- Immunology top 10%
- Biomaterials top 5%
- Oncology
- Co-authors
- Xing‐Jie LiangJinghong LiYuxuan ZhangChunrong YangJinjin WangYuchen YangYujie LiJinchao Zhang
- Topics
- Nanoplatforms for cancer theranostics (7 papers)Immunotherapy and Immune Responses (5 papers)CAR-T cell therapy research (3 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyAdvanced Materials
- Partner nations
- ChinaNew ZealandSwitzerland
In The Last Decade
Qiankun Ni
17 papers receiving 927 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Molecular Biology 435
- Biomedical Engineering 416
- Immunology 265
- Biomaterials 194
- Oncology 169
Countries citing papers authored by Qiankun Ni
This map shows the geographic impact of Qiankun Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiankun Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiankun Ni more than expected).
Fields of papers citing papers by Qiankun Ni
This network shows the impact of papers produced by Qiankun Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiankun Ni. The network helps show where Qiankun Ni may publish in the future.
Co-authorship network of co-authors of Qiankun Ni
This figure shows the co-authorship network connecting the top 25 collaborators of Qiankun Ni. A scholar is included among the top collaborators of Qiankun Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiankun Ni. Qiankun Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 47 | |
| 4 | 22 | |
| 5 | 1 | |
| 6 | 13 | |
| 7 | 22 | |
| 8 | Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumorsbreakdown → | 129 |
| 9 | 26 | |
| 10 | 67 | |
| 11 | 68 | |
| 12 | 255 | |
| 13 | 44 | |
| 14 | 81 | |
| 15 | 49 | |
| 16 | 79 | |
| 17 | 27 |
About Qiankun Ni
Qiankun Ni is a scholar working on Immunology, Internal Medicine and Physiology, having authored 17 papers that have together received 935 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Biomaterials (194 citations), Immunology (265 citations) and Biomedical Engineering (416 citations). Qiankun Ni has collaborated with scholars based in China, New Zealand and Switzerland. Frequent co-authors include Xing‐Jie Liang, Jinghong Li, Yuxuan Zhang, Chunrong Yang, Jinjin Wang, Yuchen Yang, Yujie Li, Jinchao Zhang, Guangchao Qing and Ningqiang Gong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.